Feb 27, 2026 08:13AM

Feb 27, 2026 08:11AM

Feb 19, 2026 05:31PM

Feb 17, 2026 10:48AM

Feb 16, 2026 05:31PM

Feb 10, 2026 07:00AM

Jan 30, 2026 09:29AM Incyte gets positive CHMP opinion for anal cancer drug Zynyz

Jan 30, 2026 09:29AM

Jan 5, 2026 01:33PM

Jan 5, 2026 07:30AM

Jan 5, 2026 07:30AM

Dec 22, 2025 05:40AM

Dec 22, 2025 02:44AM

Dec 22, 2025 02:42AM Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer

Dec 17, 2025 11:20AM

Dec 17, 2025 11:20AM

Dec 8, 2025 04:30PM

Dec 8, 2025 04:30PM

Dec 8, 2025 02:53AM

Dec 8, 2025 02:53AM

Dec 7, 2025 09:30AM Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA

Dec 7, 2025 09:30AM

Dec 2, 2025 09:15AM

Dec 1, 2025 08:01AM

Dec 1, 2025 08:00AM

Nov 17, 2025 03:57AM

Nov 17, 2025 01:00AM

Nov 16, 2025 03:00PM Where can biotech stocks go from here? RBC answers

Nov 6, 2025 09:15AM

Nov 3, 2025 09:31AM

Oct 28, 2025 07:00AM

Oct 27, 2025 07:30AM

Oct 27, 2025 07:30AM

Oct 25, 2025 07:55PM

Oct 24, 2025 06:45AM Lilly's baricitinib shows hair regrowth in adolescents with alopecia areata

Oct 24, 2025 06:45AM

Oct 19, 2025 01:30PM

Oct 19, 2025 01:30PM

Oct 12, 2025 06:05PM

Sep 28, 2025 12:20AM

Sep 22, 2025 07:30AM

Sep 22, 2025 07:30AM Incyte Announces the Appointment of Dave Gardner as Executive Vice President and Chief Strategy Officer

Sep 22, 2025 04:39AM

Sep 18, 2025 04:21PM

Sep 18, 2025 04:21PM

Sep 17, 2025 01:01AM

Sep 17, 2025 01:00AM

Sep 10, 2025 07:30AM

Sep 3, 2025 09:15AM Incyte launches awareness campaign for hidradenitis suppurativa patients

Sep 3, 2025 09:15AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All